在基因组挖掘的指导下发现了库马鲁布林:一种新的氨基库马林替代的鲁布罗米抗生素抗生素
Heiner G Weddeling1, Sven T Sowa1, Selina Bosshardt1
1Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Journal of industrial microbiology & biotechnology
|July 4, 2025
概括
研究人员发现了库马鲁布林,这是由Actinobacteria产生的新型抗生素鲁布罗米. 这种芳香的多基化物具有独特的氨基库马林替代剂,并且对阳性细菌表现出强烈的活性.
科学领域:
- 自然产品化学 自然产品化学
- 微生物学 微生物学
- 合成生物学 合成生物学
背景情况:
- 鲁布罗米是一种具有细胞毒性和抗菌性芳香多基基酸,具有螺旋核.
- 已知rubromycin的 hialuromycin 具有一个独特的 2-amino-3-hydroxycyclopent-2-enone (C5N) 替代剂.
- 胺基键合成酶 (ABS) 参与了这种独特的替代剂的形成.
研究的目的:
- 通过探索未经表征的生物合成基因集群来识别新型鲁布罗米衍生物.
- 调查潜在的鲁布罗米生产商缺乏C5N形成酶,用于新型替代剂.
- 来自Lentzea tibetensis的一种新的rubromycin模拟物的特征.
主要方法:
- 细菌基因组的生物信息分析,以确定生物合成基因集群.
- 培养精选的细菌菌株,包括Lentzea tibetensis.
- 使用高分辨率质谱法 (HRMS) 和核磁共振 (NMR) 谱法阐明结构.
- 通过电子圆二极化 (ECD) 光谱测定绝对配置.
- 在体外对抗细菌菌株的生物活性测定.
主要成果:
- 鉴定Lentzea tibetensis作为一种新型鲁布罗米衍生物的生产者.
- 新化合物的表征为库马鲁,含有氨基库马林部分.
- 证实了库马鲁布林的绝对配置与已知的鲁布罗米辛相匹配.
- 证明了库马鲁布林对格拉姆阳性细菌的强烈抑制活性.
结论:
- 发现了库马鲁,一种新型的氨基库马林替代的rubromycin.
- 丁丁 (Lentzea tibetensis) 是一种具有潜在抗生素应用的新型天然产品的来源.
- 这些发现扩大了rubromycins的结构多样性,并突出了生物信息引导自然产品发现的实用性.
更多相关视频
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
17.4K
08:54Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
19.1K
相关概念视频
Antibiotic Selection
55.3K
Overview
55.3K
Riboswitches
8.6K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.6K
Development of Antibiotic Resistance
219
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
219
